Verified email-pattern data for Surface Oncology Inc. is currently limited. You can still use the company insights and contact sections below.
Surface Oncology is a clinical-stage immuno-oncology company focused on using its specialized knowledge of the biological pathways critical to the immunosuppressive tumor microenvironment (TME) for the development of next-generation therapies to help patients suffering with cancer. Recent advances in understanding how the immune system fights cancer has created a first wave of immunotherapies with profound benefits for some patients. These first-generation therapies, or "checkpoint inhibitors", have been groundbreaking, but only a relatively small subset of patients is deriving long-term benefit. We believe that the lack of a broad and sustained clinical response is because these first-generation therapies only target one component of the immunosuppressive TME and a broader, more multi-faceted therapeutic approach is required.
We are a team on a mission to deliver transformative outcomes for people with cancer by breaking through the frontiers of immuno-oncology research. Our diverse clinical and preclinical pipeline of immune-enhancing antibody candidates target the innate and adaptive arms of the immune system to deliver dramatically different therapies for patients and their families.
Surface is leveraging its deep understanding of TME biology to target factors and cells that suppress patients’ anti-tumor immune response. Our broad attack on the TME has the potential to convert patients’ non-responsive ‘cold’ tumors into immune-active ones. We push ourselves to break through across all dimensions of our work.
From a discovery perspective, Surface leverages its world-class SAB to identify new targets and takes an aggressive approach towards generating diverse, highly-specific antibodies, which allows our scientists to thoroughly explore the relevant biology. Our antibody discovery approach generates therapeutic-quality antibodies, as well as unique tools to explore the biology of the tumor microenvironment.
Company Details
- Employees
- 9
- Founded
- -
- Address
- 50 Hampshire Street,
- Industry
- Biotechnology Research
- Website
- http://www.surfaceoncology.com
- HQ
- Cambridge, MA
Surface Oncology Inc. Questions
Surface Oncology Inc.'s website is http://www.surfaceoncology.com
Surface Oncology Inc.'s LinkedIn profile is https://www.linkedin.com/company/surface-oncology
Surface Oncology Inc. has
9 employees.
View email and phone details for 9
employees at Surface Oncology Inc..
Surface Oncology Inc.'s industry is
Biotechnology Research
Surface Oncology Inc.'s top competitors are
Beam Therapeutics,
Infinity Pharmaceuticals,
Coherus Oncology,
Verastem Oncology,
Rapport Therapeutics,
Aveo Oncology,
Clasp Therapeutics,
Jounce Therapeutics, Inc.,
Elevation Oncology,
Strata Oncology.
Surface Oncology Inc.'s categories are Biotechnology Research
Surface Oncology Inc.'s founding year is 2014
Explore related pages
Related company profiles:
Top Surface Oncology Inc. Employees
-
Linda LoPresti
--
Somerville, Massachusetts, United States, United States1surfaceoncology.com
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.